Tolerance of daily low-dose aspirin does not preclude aspirin-exacerbated respiratory disease

J Allergy Clin Immunol Pract. 2015 May-Jun;3(3):449-51. doi: 10.1016/j.jaip.2015.01.007. Epub 2015 Jan 26.

Authors

Kathleen Lee-Sarwar¹, Christina Johns², Tanya M Laidlaw³, Katherine N Cahill⁴

Affiliations

¹ Department of Medicine, Harvard Medical School, Boston, Mass.
² Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, Mass.
³ Department of Medicine, Harvard Medical School, Boston, Mass; Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, Mass.
⁴ Department of Medicine, Harvard Medical School, Boston, Mass; Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, Mass. Electronic address: kncahill@partners.org.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Age Factors
Anti-Inflammatory Agents, Non-Steroidal / administration & dosage*
Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
Aspirin / administration & dosage*
Aspirin / adverse effects*
Asthma, Aspirin-Induced / diagnosis
Asthma, Aspirin-Induced / etiology*
Asthma, Aspirin-Induced / physiopathology
Boston
Drug Administration Schedule
Drug Tolerance*
Female
Forced Expiratory Volume
Humans
Lung / drug effects*
Lung / physiopathology
Male
Middle Aged
Predictive Value of Tests
Prognosis
Registries
Retrospective Studies
Risk Factors

Substances

Anti-Inflammatory Agents, Non-Steroidal
Aspirin

Grants and funding